company background image
A082800 logo

Vivozon Pharmaceutical KOSDAQ:A082800 Stock Report

Last Price

₩6.10k

Market Cap

₩292.3b

7D

-1.6%

1Y

90.6%

Updated

25 Nov, 2024

Data

Company Financials

Vivozon Pharmaceutical Co., Ltd.

KOSDAQ:A082800 Stock Report

Market Cap: ₩292.3b

A082800 Stock Overview

Researches, develops, produces, and sells LED products primarily in South Korea. More details

A082800 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health5/6
Dividends0/6

Vivozon Pharmaceutical Co., Ltd. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Vivozon Pharmaceutical
Historical stock prices
Current Share Price₩6,100.00
52 Week High₩7,130.00
52 Week Low₩2,715.00
Beta-0.25
11 Month Change24.49%
3 Month Change57.22%
1 Year Change90.63%
33 Year Change15.09%
5 Year Change-55.80%
Change since IPO-89.16%

Recent News & Updates

Recent updates

Vivozon Pharmaceutical Co., Ltd.'s (KOSDAQ:082800) Shares Climb 35% But Its Business Is Yet to Catch Up

Oct 28
Vivozon Pharmaceutical Co., Ltd.'s (KOSDAQ:082800) Shares Climb 35% But Its Business Is Yet to Catch Up

What Vivozon Pharmaceutical Co., Ltd.'s (KOSDAQ:082800) 33% Share Price Gain Is Not Telling You

Aug 02
What Vivozon Pharmaceutical Co., Ltd.'s (KOSDAQ:082800) 33% Share Price Gain Is Not Telling You

Vivozon Pharmaceutical (KOSDAQ:082800) Has A Somewhat Strained Balance Sheet

Jul 29
Vivozon Pharmaceutical (KOSDAQ:082800) Has A Somewhat Strained Balance Sheet

Some Shareholders Feeling Restless Over Vivozon Pharmaceutical Co., Ltd.'s (KOSDAQ:082800) P/S Ratio

Jun 04
Some Shareholders Feeling Restless Over Vivozon Pharmaceutical Co., Ltd.'s (KOSDAQ:082800) P/S Ratio

We Think Vivozon Pharmaceutical (KOSDAQ:082800) Has A Fair Chunk Of Debt

Mar 23
We Think Vivozon Pharmaceutical (KOSDAQ:082800) Has A Fair Chunk Of Debt

Is Vivozon Healthcare (KOSDAQ:082800) A Risky Investment?

May 06
Is Vivozon Healthcare (KOSDAQ:082800) A Risky Investment?

Estimating The Intrinsic Value Of Vivozon Healthcare, Inc. (KOSDAQ:082800)

Feb 18
Estimating The Intrinsic Value Of Vivozon Healthcare, Inc. (KOSDAQ:082800)

Did You Miss Vivozon Healthcare's (KOSDAQ:082800) Impressive 116% Share Price Gain?

Dec 04
Did You Miss Vivozon Healthcare's (KOSDAQ:082800) Impressive 116% Share Price Gain?

Shareholder Returns

A082800KR SemiconductorKR Market
7D-1.6%-1.0%2.9%
1Y90.6%10.9%-2.8%

Return vs Industry: A082800 exceeded the KR Semiconductor industry which returned 10.9% over the past year.

Return vs Market: A082800 exceeded the KR Market which returned -2.8% over the past year.

Price Volatility

Is A082800's price volatile compared to industry and market?
A082800 volatility
A082800 Average Weekly Movement13.4%
Semiconductor Industry Average Movement6.6%
Market Average Movement5.6%
10% most volatile stocks in KR Market11.6%
10% least volatile stocks in KR Market2.7%

Stable Share Price: A082800's share price has been volatile over the past 3 months compared to the KR market.

Volatility Over Time: A082800's weekly volatility (13%) has been stable over the past year, but is still higher than 75% of KR stocks.

About the Company

FoundedEmployeesCEOWebsite
2002318Jin Leewww.lumimicro.com

Vivozon Pharmaceutical Co., Ltd. researches, develops, produces, and sells LED products primarily in South Korea. The company offers LED packages for interior, general, indoor, decorative, and automotive lighting, as well as display applications. It also provides LED set linear lamps, including panel lamps, down lights, and flood lights for residential, commercial, and industrial structures, as well as lights for parking lots.

Vivozon Pharmaceutical Co., Ltd. Fundamentals Summary

How do Vivozon Pharmaceutical's earnings and revenue compare to its market cap?
A082800 fundamental statistics
Market cap₩292.29b
Earnings (TTM)-₩2.72b
Revenue (TTM)₩81.52b

3.6x

P/S Ratio

-107.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A082800 income statement (TTM)
Revenue₩81.52b
Cost of Revenue₩42.63b
Gross Profit₩38.89b
Other Expenses₩41.61b
Earnings-₩2.72b

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)-56.86
Gross Margin47.71%
Net Profit Margin-3.34%
Debt/Equity Ratio36.3%

How did A082800 perform over the long term?

See historical performance and comparison